A report on the work by BCM researchers with fibroblast growth factor receptor 1 appears today in the journal Cancer Cell.
“Since we are manipulating the target gene itself, we can ask, what will happen" If we turn it off, what happens" That recapitulates the effect of a specific drug,” said Dr. David Spencer, professor of immunology at BCM. “By turning the gene on and off at various time points, we can define a ‘susceptibility window’ for that drug, a time in the progression of the disease when the gene would be an appropriate target.”
That therapeutic “window” defines the time when shutting off the gene would also shut down progression of the cancer. Previous studies show that fibroblast growth factor receptor 1 may have a role in initiating prostate cancer, he said. As a result, some companies have developed drugs designed to block the receptor. Spencer’s work looks at what would happen if the receptor is blocked.
In his mouse, he used a synthetic drug that turned the re-engineered fibroblast growth factor receptor on. As the gene product was activated, the prostate gland began dramatic, synchronized changes characteristic of cancer. However, when he withdrew the drug that turned the receptor on, the changes reversed over several weeks until the prostate gland appeared normal.
However, at a certain point, changes in the tissue reach a point of no-return and transform in to a kind of cancer called adenocarcinoma that does not appear to be reversible, although withdrawing the drug can slow the cancer, too.
During this study, Spencer, his graduate student, Victor Acevedo and their colleagues also studied the changes prostate cells undergo while they spread outside the gland and into surrounding tissue. Understanding the events that take place in cells during the transition from normal to cancer can provide important clues about cancer and potential treatments.
From this study, he has identified some of the genes involved in the transition from normal prostate cells within a secretory gland to more migratory, malignant cells outside the gland. Using special gene chips called tumor microarrays, they have also discovered the up regulation or increase in cellular levels of Fzd4, a gene that might prove to be a new marker for human prostate cancer.
“Victor started out looking for a role of fibroblast growth factor receptor 1 in prostate cancer progression and ended up with a new cancer marker and a model for epithelial cell plasticity, rounding out his productive thesis,” Spencer added.
One step closer to reality
20.04.2018 | Max-Planck-Institut für Entwicklungsbiologie
The dark side of cichlid fish: from cannibal to caregiver
20.04.2018 | Veterinärmedizinische Universität Wien
University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.
Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.
Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.
Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...
Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.
The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...
Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.
Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...
In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...
13.04.2018 | Event News
12.04.2018 | Event News
09.04.2018 | Event News
20.04.2018 | Physics and Astronomy
20.04.2018 | Interdisciplinary Research
20.04.2018 | Physics and Astronomy